• L Steed, R Kong, J Stygall, J Acharya, M Bolla, M J Harrison, S E Humphries, and S P Newman.
• Department of Psychiatry and Behavioural Sciences, Centre for Cardiovascular Genetics, University College London, England.
• Ann. Thorac. Surg. 2001 Mar 1; 71 (3): 823-6.

BackgroundRecently, Tardiff and colleagues have suggested that the presence of the apolipoprotein E, epsilon4 allele was associated with increased likelihood of cognitive decline after coronary artery bypass grafting. The objective of the current study was to replicate this earlier work using an increased sample size. The increased sample also enabled an analysis by individual genotype in cognitive decline after coronary artery bypass grafting.MethodsApolipoprotein E genotyping was performed on 111 individuals undergoing coronary artery bypass grafting. Each participant underwent a battery of nine neuropsychological tests before operation and 4 to 7 weeks after operation.ResultsCognitive decline, assessed by both continuous Z change scores and two categoric measures of cognitive deficit, was not significantly associated with either individual apolipoprotein E genotypes or categorization by the presence or absence of the epsilon4 allele. The examination of potential moderating factors did not alter this finding.ConclusionsThis study suggests that the epsilon4 allele is not associated with cognitive decline in the weeks after coronary artery bypass grafting.

15 keywords...

hide…